Clinical Applications of Particle Therapy in Pediatric Malignancies

View at publisher Summarise with VIRAT
Authors: Madeline M. Flanagan, Ory Haisraely, Arnold C. Paulino, Susan Lynne McGovern
Cited by: 0
References: 106

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

In children, decades of survivorship magnify the harms of irradiation to normal tissues. Proton therapy (PT) leverages the Bragg peak phenomenon to maintain dose to tumor volumes while reducing dose to surrounding structures. This results in disease control comparable to photons while lowering normal tissue dose and reducing subsequent late effects. The clearest advantages occur when fields are large or when critical organs abut the target volume. Here, we discuss the clinical physics and comparative dosimetry that drive benefit across pediatric indications. We also synthesize PT outcomes for pediatric malignancies and highlight organ-specific late effects where PT reduces the incidence or severity of toxicities. We close with a brief look at the future of particle therapy for pediatric malignancies.

Fields of Study & Subjects

Radiation Therapy and Dosimetry Advanced Radiotherapy Techniques Boron Compounds in Chemistry

Publication details

Journal / source
The Cancer Journal
Volume
32
Issue
2
Publication date
1 March 2026
Language
EN